BioSpace News Archive

Business

Innoviva Appoints Stephen Basso as Chief Financial Officer

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” and “the Company”), a diversified holding company with a portfolio of royalties and other healthcare assets, today announced the appointment of Stephen Basso as its Chief Financial Officer, effective August 21, 2023.

August 25, 2023
·
5 min read
Business

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2023

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2023.

August 25, 2023
·
1 min read
Business

Biomerica Reports Fiscal 2023 Year End Results

Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2023 financial results.

August 25, 2023
·
8 min read
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

GC Biopharma announced that it has signed a MOU at its headquarters in Yongin, South Korea with Eubiologics for a co-production of Euvichol, an oral cholera vaccine.

August 25, 2023
·
2 min read
Genetown

Myomo Announces Pricing of $4.4 Million Public Offering

Myomo, Inc. announced the pricing of its “reasonable best efforts” public offering of 7,333,334 shares of common stock at a public offering price of $0.60 per share for aggregate gross proceeds of approximately $4.4 million, before deducting placement agent fees and other offering expenses.

August 25, 2023
·
5 min read
Business

Antengene Announces Interim Financial Results for 2023 with New Clinical Data Highlighting the Growing Value of Its Pipeline

Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), today announced its interim results for the six-months ended June 30, 2023, and provided updates on multiple milestones achieved since the beginning of 2023.

August 25, 2023
·
10 min read
Policy

Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA

Akeso Inc. announced that the National Center for Drug Evaluation of the State Drug Administration of the People’s Republic of China has granted priority review of New Drug Application for ivonescimab, a potential first-in-class investigational PD-1/VEGF bi-specific antibody.

August 25, 2023
·
4 min read
Job Trends

Thermo Fisher Scientific to Present at Handelsbanken 3rd Annual Life Science Innovation Day on August 30th, 2023

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Handelsbanken 3rd Annual Life Science Innovation Day on Wednesday, August 30th, 2023 at 10:00 a.m. (EDT).

August 25, 2023
·
1 min read
Ceapro Extends Exclusive International Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise

Ceapro Inc. announced the signing of an amendment to its long-term agreement with German-based multinational, Symrise AG, for the distribution and commercialization of Ceapro’s high value active ingredients to major key international players in the cosmetic market.

August 25, 2023
·
3 min read
Business

IIOT-OXYS, Inc. Reports 2023 Form 10-Q Second Quarter Results and Upcoming Investor Conference Call

IIOT-OXYS, Inc. (OTC PINK:ITOX) (“Oxys” or the “Company”) announced its financial results for the six months ended June 30, 2023, and an upcoming Investor Conference Call on Tuesday, August 29, 2023.

August 25, 2023
·
6 min read